When the FDA e-cig regulations were first announced on May 5, 2016, many retailers and manufacturers were completely unaware of the significant role that Big Pharma played in their creation.    As far back as the late 1990’s, pharmaceutical companies were already well aware of the many health benefits of electronic vaping devices.  Companies like GlaxoSmithKline, Johnson & Johnson, and Squibb quickly determined that the delivery of prescription medications would be cheaper and more immediately effective when injected through these devices.

At the same time, Big Pharma also successfully predicted that e-cigs would become even more popular among smokers, especially those who were trying to quit. Unfortunately, pharmaceutical company GlaxoSmithKline already offered Nicorette Gum as a smoking cessation method.  Meanwhile, “The Patch” by Big Pharma’s Johnson & Johnson was also raking in big bucks.  So when the Williamson Tobacco Corporation accused the FDA of overstepping its authority to regulate tobacco products in 1998, Big Pharma was watching.